BamSEC and AlphaSense Join Forces
Learn More

CytoSorbents Corporation

NASDAQ: CTSO    
Share price (11/22/24): $0.92    
Market cap (11/22/24): $50.3 million

Credit Agreements Filter

EX-10.2
from 8-K 8 pages Certain Portions of This Exhibit Have Been Redacted Because the Information Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential. Redacted Information Has Been Noted in This Document With a Placeholder Identified by the Mark “[*]”. Supplement to the Loan and Security Agreement Dated as of June 28, 2024 Among Cytosorbents Corporation (“Parent”) and Cytosorbents Medical Inc. (“Medical”; and Together With Parent, Jointly and Severally, Individually and Collectively, “Borrower”) Avenue Capital Management II, L.P., a Delaware Limited Partnership, as Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and Avenue Venture Opportunities Fund, L.P. II, a Delaware Limited Partnership (“Avenue 2”), as a Lender and Avenue Venture Opportunities Fund, L.P., a Delaware Limited Partnership (“Avenue”), as a Lender
12/34/56
EX-10.1
from 8-K 31 pages Certain Portions of This Exhibit Have Been Redacted Because the Information Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential. Redacted Information Has Been Noted in This Document With a Placeholder Identified by the Mark “[*]”. Loan and Security Agreement Dated as of June 28, 2024 Among Cytosorbents Corporation, a Delaware Corporation, (“Parent”) and Cytosorbents Medical Inc. a Delaware Corporation, (“Medical”; and Together With Parent, Jointly and Severally, Individually and Collectively, “Borrower”) and Avenue Capital Management II, L.P., a Delaware Limited Partnership (As Administrative Agent and Collateral Agent (In Such Capacity “Agent”) and Avenue Venture Opportunities Fund II, L.P., a Delaware Limited Partnership, (“Avenue 2“) as a Lender and Avenue Venture Opportunities Fund, L.P., a Delaware Limited Partnership (“Avenue“) as a Lender (In Such Capacity, With Avenue 2, a “Lender” and Collectively, the “Lenders”) Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 3 pages Fifth Amendment to the Amended and Restated Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 5 pages Fourth Amendment to the Amended and Restated Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 6 pages Third Amendment to the Amended and Restated Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 5 pages First Amendment to the Amended and Restated Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 39 pages Cytosorbents Corporation, a Delaware Corporation Cytosorbents Medical, Inc., a Delaware Corporation Western Alliance Bank, an Arizona Corporation Amended and Restated Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 39 pages Cytosorbents Corporation, a Delaware Corporation Cytosorbents Medical, Inc., a Delaware Corporation Western Alliance Bank, an Arizona Corporation Loan and Security Agreement
12/34/56